Cha Y J, Pearson V E
Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD 21287, USA.
Ann Pharmacother. 1999 Sep;33(9):936-8. doi: 10.1345/aph.18396.
To report a case of angioedema associated with the angiotensin II receptor antagonist losartan.
A 62-year-old African-American woman was admitted to the hospital for acute renal failure and uncontrolled hypertension. After attempting blood pressure control with three different agents, captopril was combined with metoprolol. The patient noted swelling of the lips combined with shortness of breath after four days of captopril. Losartan was substituted for captopril, which then produced similar swelling of the lips (without shortness of breath) after only one dose. These symptoms resolved after discontinuation of losartan and administration of antihistamines.
Losartan, like other angiotensin II receptor antagonists, blocks the action of angiotensin II at the receptor level. Five published case reports involved patients with a prior history of intolerance to the angiotensin-converting enzyme inhibitors. Two published case reports of similar reactions also occurred in patients with renal compromise. The mechanism for this reaction from losartan is not known, but may not be due to bradykinin excess.
Clinicians should be aware that angiotensin receptor antagonists may not be safe alternatives in patients who have a history of angioedema secondary to the angiotensin-converting enzyme inhibitors.
报告1例与血管紧张素II受体拮抗剂氯沙坦相关的血管性水肿病例。
一名62岁的非裔美国女性因急性肾衰竭和高血压控制不佳入院。在用三种不同药物尝试控制血压后,卡托普利与美托洛尔联合使用。患者在服用卡托普利4天后出现嘴唇肿胀并伴有呼吸急促。用氯沙坦替代卡托普利后,仅一剂就出现了类似的嘴唇肿胀(无呼吸急促)。停用氯沙坦并给予抗组胺药后,这些症状消失。
氯沙坦与其他血管紧张素II受体拮抗剂一样,在受体水平阻断血管紧张素II的作用。5篇已发表的病例报告涉及既往有血管紧张素转换酶抑制剂不耐受史的患者。另外2篇已发表的类似反应病例报告也发生在肾功能不全患者中。氯沙坦引起这种反应的机制尚不清楚,但可能不是由于缓激肽过多所致。
临床医生应意识到,对于有血管紧张素转换酶抑制剂继发血管性水肿病史的患者,血管紧张素受体拮抗剂可能不是安全的替代药物。